These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble. Tanboon J; Sanmaneechai O; Charuvanij S; Sangruchi T; Galindo-Feria AS; Lundberg IE; Ohnuki Y; Shiina T; Suzuki S; Nishino I Neuromuscul Disord; 2019 Jul; 29(7):543-548. PubMed ID: 31204143 [TBL] [Abstract][Full Text] [Related]
3. Dengue infection triggered immune mediated necrotizing myopathy in children: a case report and literature review. Mekmangkonthong A; Amornvit J; Numkarunarunrote N; Veeravigrom M; Khaosut P Pediatr Rheumatol Online J; 2022 Jun; 20(1):40. PubMed ID: 35672822 [TBL] [Abstract][Full Text] [Related]
4. Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statins. Khan F; Brady S; Kuttikat A Rheumatol Int; 2023 Feb; 43(2):383-390. PubMed ID: 36260115 [TBL] [Abstract][Full Text] [Related]
5. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins. Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224 [TBL] [Abstract][Full Text] [Related]
6. Anti-HMGCR myopathy: barriers to prompt recognition. Barp A; Merve A; Shah S; Desikan M; Hanna MG; Bugiardini E Pract Neurol; 2023 Jun; 23(3):239-242. PubMed ID: 36564213 [TBL] [Abstract][Full Text] [Related]
7. Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy. Tan E; Knight J; Khonasti S; Nolan D; McGettigan B; Bundell C; Needham M; Brusch A Intern Med J; 2023 Oct; 53(10):1846-1853. PubMed ID: 36625419 [TBL] [Abstract][Full Text] [Related]
10. A young female case of asymptomatic immune-mediated necrotizing myopathy: a potential diagnostic option of antibody testing for rhabdomyolysis. Sasaki R; Yunoki T; Nakano Y; Fukui Y; Takemoto M; Morihara R; Katsuyama E; Nishino I; Yamashita T Neuromuscul Disord; 2023 Feb; 33(2):183-186. PubMed ID: 36652875 [TBL] [Abstract][Full Text] [Related]
11. What Is in the Myopathy Literature? Al-Lahham T; Lacomis D J Clin Neuromuscul Dis; 2022 Sep; 24(1):38-48. PubMed ID: 36005472 [TBL] [Abstract][Full Text] [Related]
12. [Anti-HMGCR immune-mediated necrotizing myopathy: A case report]. Zhang YJ; Ma JY; Liu XY; Zheng DF; Zhang YS; Li XG; Fan DS Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):558-562. PubMed ID: 37291935 [TBL] [Abstract][Full Text] [Related]
13. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management. Basharat P; Christopher-Stine L Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574 [TBL] [Abstract][Full Text] [Related]
14. Immune-mediated necrotizing myopathy: Unusual presentations of a treatable disease. Nicolau S; Milone M; Tracy JA; Mills JR; Triplett JD; Liewluck T Muscle Nerve; 2021 Dec; 64(6):734-739. PubMed ID: 34617293 [TBL] [Abstract][Full Text] [Related]